ReviewTherapeutic advances in neurological disorders2016

Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.

Finn Sellebjerg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.